Pfizer Enters China's GLP-1 Market with Xianweiying Pre-Orders, Intensifies Weight-Loss Drug Race Written By sheeba farhat26 April 2026 9:30 AM ISTNew Delhi: Pfizer's GLP-1 weight management treatment Xianweiying is available for pre-order in China, ​a Reuters check on a local e-commerce...
Lilly's Foundayo Clocks 1,390 Prescriptions in Debut Week as Oral Obesity Drug Race Heats Up Written By sheeba farhat19 April 2026 12:09 PM ISTNew Delhi: Eli Lilly's newly launched weight-loss pill was prescribed 1,390 ‌times in the U.S. in its first week of sales, according to analysts who...
USFDA Flags Liver Safety Concerns, Asks Eli Lilly for Additional Data on Obesity Pill Foundayo Written By sheeba farhat15 April 2026 7:35 PM ISTNew Delhi: The U.S. Food and Drug Administration has asked Eli Lilly for more data on liver injury linked to its newly approved ​obesity pill,...
AI Meets Pharma: Novo Nordisk Teams Up with OpenAI for Faster Drug Innovation Written By sheeba farhat15 April 2026 7:00 PM ISTNew Delhi: Danish pharmaceuticals group Novo Nordisk, maker of the popular Ozempic and Wegovy anti-obesity drugs, announced Tuesday a "strategic...
Wegovy HD Rollout: Novo Nordisk Introduces 7.2 mg Dose in US Market Written By MD Bureau8 April 2026 7:10 PM ISTBengaluru: Novo Nordisk said on Tuesday that it has made a higher-dose version of its blockbuster weight-loss drug Wegovy available across the United...
Oral Weight-Loss Pills Gain Ground as Patients Prefer Cheaper, Needle-Free Options Over Injections Written By sheeba farhat7 April 2026 10:00 AM ISTWashington: Americans starting weight-loss medicines for the first time want lower cost and greater convenience as they consider pills from Novo...
USFDA Approves Eli Lilly's Weight-Loss Pill Foundayo, Intensifies Rivalry with Novo Nordisk Written By sheeba farhat3 April 2026 2:49 PM ISTWashington: The U.S. FDA on Wednesday approved Eli Lilly's weight-loss pill, setting up the next battle with Novo Nordisk for the millions of...
FDA Approves Once Weekly Insulin Icodec for Type 2 Diabetes Written By Dr. Kamal Kant Kohli30 March 2026 9:30 AM ISTThe US Food and Drug Administration has approved insulin icodec (Awiqli), developed by Novo Nordisk, as the first once-weekly long-acting basal...
Delhi HC Bars Dr Reddy's from Selling Olymviq Over Similarity with Novo Nordisk's Ozempic Written By Susmita Roy27 March 2026 10:16 PM ISTNew Delhi: The Delhi High Court on Wednesday directed Dr. Reddy's Laboratories to temporarily stop selling its diabetes drug marketed under the brand...
Novo Slashes Wegovy Prices Amid Lilly's Mounjaro Surge in South African Market Written By sheeba farhat26 March 2026 11:24 PM ISTJohannesburg: Novo Nordisk is cutting South African prices of its weight-loss drug Wegovy for a second time since it launched in August, local...
USFDA Approves Higher-Dose Wegovy to Boost Weight Loss Outcomes Written By sheeba farhat21 March 2026 11:00 AM ISTWashington: Federal regulators on Thursday approved a new higher-dose version of the blockbuster obesity drug Wegovy that may help users lose more...
Semaglutide Patent Expiry Sparks Generic Rush in India, Prices Set to Drop Sharply Written By sheeba farhat20 March 2026 11:13 PM ISTHyderabad: India's market for diabetes and weight-loss drugs is set for a shake-up as Danish drugmaker Novo Nordisk's patent on semaglutide expires...
